Sutro Biopharma (STRO) Competitors $2.89 -0.56 (-16.23%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends STRO vs. ANIP, ARQT, SAVA, CALT, ZYME, AVDL, BCAX, COGT, BCYC, and AVBPShould you be buying Sutro Biopharma stock or one of its competitors? The main competitors of Sutro Biopharma include ANI Pharmaceuticals (ANIP), Arcutis Biotherapeutics (ARQT), Cassava Sciences (SAVA), Calliditas Therapeutics AB (publ) (CALT), Zymeworks (ZYME), Avadel Pharmaceuticals (AVDL), Bicara Therapeutics (BCAX), Cogent Biosciences (COGT), Bicycle Therapeutics (BCYC), and ArriVent BioPharma (AVBP). These companies are all part of the "pharmaceutical products" industry. Sutro Biopharma vs. ANI Pharmaceuticals Arcutis Biotherapeutics Cassava Sciences Calliditas Therapeutics AB (publ) Zymeworks Avadel Pharmaceuticals Bicara Therapeutics Cogent Biosciences Bicycle Therapeutics ArriVent BioPharma Sutro Biopharma (NASDAQ:STRO) and ANI Pharmaceuticals (NASDAQ:ANIP) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership, community ranking and earnings. Do analysts recommend STRO or ANIP? Sutro Biopharma currently has a consensus target price of $12.14, suggesting a potential upside of 320.17%. ANI Pharmaceuticals has a consensus target price of $77.33, suggesting a potential upside of 36.68%. Given Sutro Biopharma's stronger consensus rating and higher possible upside, research analysts plainly believe Sutro Biopharma is more favorable than ANI Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sutro Biopharma 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00ANI Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Which has more risk and volatility, STRO or ANIP? Sutro Biopharma has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, ANI Pharmaceuticals has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Does the MarketBeat Community prefer STRO or ANIP? ANI Pharmaceuticals received 303 more outperform votes than Sutro Biopharma when rated by MarketBeat users. However, 65.82% of users gave Sutro Biopharma an outperform vote while only 64.48% of users gave ANI Pharmaceuticals an outperform vote. CompanyUnderperformOutperformSutro BiopharmaOutperform Votes12965.82% Underperform Votes6734.18% ANI PharmaceuticalsOutperform Votes43264.48% Underperform Votes23835.52% Do institutionals & insiders have more ownership in STRO or ANIP? 97.0% of Sutro Biopharma shares are owned by institutional investors. Comparatively, 76.1% of ANI Pharmaceuticals shares are owned by institutional investors. 5.9% of Sutro Biopharma shares are owned by company insiders. Comparatively, 12.7% of ANI Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media favor STRO or ANIP? In the previous week, ANI Pharmaceuticals had 3 more articles in the media than Sutro Biopharma. MarketBeat recorded 11 mentions for ANI Pharmaceuticals and 8 mentions for Sutro Biopharma. ANI Pharmaceuticals' average media sentiment score of 0.67 beat Sutro Biopharma's score of 0.34 indicating that ANI Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sutro Biopharma 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral ANI Pharmaceuticals 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is STRO or ANIP more profitable? ANI Pharmaceuticals has a net margin of -1.28% compared to Sutro Biopharma's net margin of -77.01%. ANI Pharmaceuticals' return on equity of 15.87% beat Sutro Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Sutro Biopharma-77.01% -101.89% -28.69% ANI Pharmaceuticals -1.28%15.87%6.88% Which has stronger valuation & earnings, STRO or ANIP? ANI Pharmaceuticals has higher revenue and earnings than Sutro Biopharma. ANI Pharmaceuticals is trading at a lower price-to-earnings ratio than Sutro Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSutro Biopharma$153.73M1.55-$106.79M-$1.61-1.80ANI Pharmaceuticals$555.46M2.14$18.78M-$0.55-102.87 SummaryANI Pharmaceuticals beats Sutro Biopharma on 11 of the 18 factors compared between the two stocks. Ad WealthPressHow one pattern has averaged an 85% return per year since the pandemic. Over the last 5 years Roger Scott has done some pretty incredible things… He’s found hundreds of winning opportunities… He’s created some incredible strategies… And he’s even designed some amazing tools… But there is one thing he’s always kept close to the chest… And in this case, it’s been a very particular stock market pattern…. A pattern he calls the World's Most Predictable Pattern…Follow this link here and enter your email address to sign up… Get Sutro Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for STRO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STRO vs. The Competition Export to ExcelMetricSutro BiopharmaBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$238.31M$2.91B$5.07B$8.66BDividend YieldN/A1.79%5.10%4.06%P/E Ratio-1.8041.61100.6017.27Price / Sales1.55217.681,195.1369.06Price / CashN/A178.0141.0336.35Price / Book2.144.096.345.87Net Income-$106.79M-$42.42M$119.64M$225.66M7 Day Performance-34.02%-10.63%-5.13%-1.34%1 Month Performance-22.10%-5.81%-2.72%1.15%1 Year Performance7.43%24.19%31.10%24.02% Sutro Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STROSutro Biopharma4.3681 of 5 stars$2.89-16.2%$12.14+320.2%+23.0%$238.31M$153.73M-1.80240Analyst RevisionNews CoverageHigh Trading VolumeANIPANI Pharmaceuticals4.4145 of 5 stars$59.83-1.9%N/A+10.4%$1.26B$486.82M-108.78642Earnings ReportShort Interest ↑High Trading VolumeARQTArcutis Biotherapeutics2.0907 of 5 stars$10.47+2.1%N/A+374.9%$1.23B$59.61M-5.85150Positive NewsSAVACassava Sciences3.7715 of 5 stars$25.18-4.5%N/A+72.0%$1.21BN/A-18.2530Gap UpCALTCalliditas Therapeutics AB (publ)0.1943 of 5 stars$40.00flatN/AN/A$1.19B$1.60B-21.62180News CoverageZYMEZymeworks2.1009 of 5 stars$17.21-1.1%N/A+97.8%$1.19B$76.01M-11.47290AVDLAvadel Pharmaceuticals2.6305 of 5 stars$12.02-8.6%N/A+1.8%$1.16B$27.96M-15.21154Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading VolumeBCAXBicara Therapeutics3.5757 of 5 stars$22.00-1.6%N/AN/A$1.14BN/A0.0032Earnings ReportAnalyst RevisionNews CoverageCOGTCogent Biosciences2.7239 of 5 stars$10.40+0.2%N/A+20.6%$1.14BN/A-4.1980Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageBCYCBicycle Therapeutics2.858 of 5 stars$23.22-0.9%N/A+55.8%$1.10B$26.98M-7.06240Insider SellingShort Interest ↑AVBPArriVent BioPharma1.029 of 5 stars$31.86-3.4%N/AN/A$1.07BN/A0.0040Analyst ForecastNews CoveragePositive News Related Companies and Tools Related Companies ANI Pharmaceuticals Alternatives Arcutis Biotherapeutics Alternatives Cassava Sciences Alternatives Calliditas Therapeutics AB (publ) Alternatives Zymeworks Alternatives Avadel Pharmaceuticals Alternatives Bicara Therapeutics Alternatives Cogent Biosciences Alternatives Bicycle Therapeutics Alternatives ArriVent BioPharma Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:STRO) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sutro Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sutro Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STRO Stock Alerts